LQDA Q4 2025 Earnings — Liquidia Corporation Revenue & Financial Results | Market Cap Arena

LQDALiquidia Corporation

$3B

Q4 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$92M+3054.6% YoY

Gross Profit

$94M101.7% margin

Operating Income

$20M21.5% margin

Net Income

$15M15.8% margin

EPS (Diluted)

$0.15

QoQ Revenue Growth

+69.3%

Cash Flow

Operating Cash Flow

$44M

Free Cash Flow

$42M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$328M

Total Liabilities

$283M

Stockholders' Equity

$45M

Cash & Equivalents

$191M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$92M	$3M	+3054.6%
Gross Profit	$94M	$2M	+5887.5%
Operating Income	$20M	-$36M	+154.8%
Net Income	$15M	-$38M	+137.9%

Revenue Segments

Product

$90M95%

Service

$5M5%